Cargando…
Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention
Metastatic recurrence in breast cancer is a major cause of mortality and often occurs many years after removal of the primary tumour. This process is driven by the reactivation of disseminated tumour cells that are characterised by mitotic quiescence and chemotherapeutic resistance. The ability to r...
Autores principales: | Quayle, Lewis A., Ottewell, Penelope D., Holen, Ingunn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267670/ https://www.ncbi.nlm.nih.gov/pubmed/30377878 http://dx.doi.org/10.1007/s10585-018-9946-2 |
Ejemplares similares
-
Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy †
por: Quayle, Lewis A., et al.
Publicado: (2021) -
The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
por: Wilson, Caroline, et al.
Publicado: (2015) -
The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells
por: Brown, Hannah K, et al.
Publicado: (2011) -
The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo
por: Allocca, Gloria, et al.
Publicado: (2019) -
IL-1 drives breast cancer growth and bone metastasis in vivo
por: Holen, Ingunn, et al.
Publicado: (2016)